US 8772013
Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
granted A61KA61K31/337A61K31/704
Quick answer
US patent 8772013 (Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells) held by EnGeneIC Molecular Delivery Pty Ltd expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- EnGeneIC Molecular Delivery Pty Ltd
- Grant date
- Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/337, A61K31/704, A61K9/0019, A61K9/5068